Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Clin Exp Allergy
LFM-A13 may be useful as a new class of chemosensitizing and apoptosis-promoting antileukemic agents for treatment of patients with chemotherapy-resistant B-lineage leukemias or lymphomas
and developmental potential
potencies which may be expected for an ATP competitive inhibitor
G-749 potently inhibits autophosphorylation of FLT3 with IC50 of ≤8 nM
CIQ - CAS# 486427-17-2 size:2mg solid Clin Exp AllergyCIQ, CAS No. 486427 17 2, is a GluN2C GluN2D subunit selective NMDA receptor potentiator, which reverses MK 801 induced impairment in prepulse inhibition and working memory in Y maze test in mice. The facilitation of GluN2C GluN2D containing receptors may serve as an important therapeutic strategy for treating positive and cognitive symptoms in schizophrenia. Product information CAS Number: 486427 17 2 Molecular Weight: 467. 94 Formula: C26H26ClNO5